Injectable semaglutide shows early promise to improve fertility in women with PMOS
Peer-Reviewed Publication
Updates every hour. Last Updated: 14-Jun-2026 20:16 ET (15-Jun-2026 00:16 GMT/UTC)
Early findings from the RESTORE trial suggest semaglutide may improve reproductive health in women with PCOS, beyond its effects on weight loss. Participants who achieved significant weight loss showed signs of improved ovulation and reproductive function sooner than expected. The results highlight semaglutide's potential to address both the metabolic and reproductive challenges associated with PCOS.
Difficulty conceiving a pregnancy may be associated with small differences in children’s learning and behavior, according to a new study funded by the Environmental influences on Child Health Outcomes (ECHO) Program at the National Institutes of Health (NIH).
The first-ever clinical practice guideline on cardiovascular-kidney-metabolic (CKM) syndrome from the American Heart Association and the American College of Cardiology details staging to assess how a person’s kidneys, metabolism and heart are functioning. Higher stages of CKM syndrome are associated with a greater burden of serious health conditions, such as Type 2 diabetes, chronic kidney disease, and a higher risk of cardiovascular disease and mortality.
University students who aren’t always enthused about walking across campus for class can take heart in new research that suggests lots of daily steps translates to improved mental health and better sleep.